Prozac Proves Beneficial Against Covid-19
Covid-19 patients who took Prozac (Fluvoxamine) for ten days were found to be 66% less likely to be hospitalized than those who didn’t, according to a large clinical trial. Prozac is in a class of antidepressants called selective serotonin reuptake inhibitors (SSRIs) that is often subscribed to treat obsessive compulsive disorder and depression. Scientists are …